(Q53238293)
Statements
Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial. (English)
Roberts R
Bavendam T
Glasser DB
Carlsson M
Eyland N
Elinoff V
1 June 2006
60
6
752-758